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Abstract 
OBJECTIVES 
A vibratory vocal fold replacement would introduce a new treatment paradigm for structural 
vocal fold diseases such as scarring and lamina propria loss. This work implants a tissue-engineered 
replacement for vocal fold lamina propria and epithelium in rabbits, and compares histology and function 
to injured controls and orthotopic transplants.  Hypotheses were that the cell-based implant would engraft 
and control the wound response, reducing fibrosis and restoring vibration.  
STUDY DESIGN 
 Translational research 
METHODS 
Rabbit adipose-derived mesenchymal stem cells (ASC) were embedded within a three-
dimensional fibrin gel, forming the Cell-based Outer Vocal fold Replacement (COVR). 16 rabbits 
underwent unilateral resection of vocal fold epithelium and lamina propria, and reconstruction with one of 
three treatments: fibrin glue alone with healing by secondary intention, replantation of autologous 
resected vocal fold cover, or COVR implantation. After four weeks, larynges were examined 
histologically and with phonation. 
RESULTS 
15 rabbits survived. All tissues incorporated well after implantation. After one month, both 
graft types improved histology and vibration relative to injured controls. Extracellular matrix (ECM) of 
the replanted mucosa was disrupted, and ECM of the COVR implants remained immature. Immune 
reaction was evident when male cells were implanted into female rabbits. Best histologic and short-term 
vibratory outcomes were achieved with COVR implants containing male cells implanted into male 
rabbits.   
CONCLUSIONS 
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Vocal fold cover replacement with a stem cell-based tissue-engineered construct is feasible and 
beneficial in acute rabbit implantation. Wound modifying behavior of the COVR implant is judged to be 
an important factor in preventing fibrosis.  
 
KEY WORDS: adipose-derived stem cell, tissue engineering, vocal fold scarring, mucosa, phonation  
 
LEVEL OF EVIDENCE: NA 
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INTRODUCTION 
 
 Regenerative medicine is being considered for difficult clinical problems throughout the body. 
The irreplaceable nature of the vibratory vocal fold (VF) is one of those challenges. Normal voicing 
requires a mobile epithelium overlying a specialized lamina propria.  That unique microstructure is 
limited to a very small geography, and does not match any other tissue.  Injury or resection alters the 
extracellular matrix (ECM) making it stiff and inelastic, and requiring greater effort to phonate. Implanted 
tissue replacements are subject to the same scar formation. Thus, a functioning VF replacement that heals 
without scarring would open new avenues of treatment for structural VF disorders.  
 Repairing injured VF lamina propria has also proven difficult. Injected steroids may improve 
function in mild-moderate scars, but the impact if any on underlying ECM has not been studied1. 
Synthetic implants and autologous tissue grafts improve voice only modestly, and do not reduce the 
aerodynamic effort for phonation2.  Basic fibroblast growth factor has shown promise, improving voice in 
small uncontrolled human reports of presbylaryngeous and scarring3,4. Suggested mechanisms include 
increased hyaluronic acid synthesis, and other ECM effects possibly mediated via hepatocyte growth 
factor upregulation5. The improvements with growth factors, which act upon multiple cellular pathways, 
hint at the utility of broad therapeutic targeting for VF scarring. Implanting cells can further extend the 
reach of therapy, by targeting multiple pathways both simultaneously and longitudinally through time, 
and by responding to host signals. This concept that cellular activity can best lead the repair work forms 
the basis for considering regenerative medicine over other, simpler, therapies.  
 Broadly speaking, regenerative medicine "replaces or regenerates human cells, tissue, or organs, 
to restore or establish normal function"6. Newly introduced cells control the repair process, via an 
assemblage of actions involving multiple pathways.  It thus differs fundamentally from traditional 
pharmaceuticals that have narrower mechanisms of action and are unresponsive to host factors7. At least 
three manifestations of autologous cell injections for VF repair have been tested in human clinical trials: 
bone marrow-derived mesenchymal stem cells8, adipose stromal cells9, and fibroblasts10. A phase 1 trial 
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of autologous fibroblasts demonstrated voice improvement in 4 of the 5 patients with scarring11. 
However, the authors reported that two patients with full-thickness scars involving epithelium and lamina 
propria did not recover mucosal mobility.  Such patients, for example those with no normal lamina 
propria remaining or with inadequate response to injectable treatments, may benefit from more extensive 
therapy.  
A more comprehensive therapy, for the most severe scars or tissue loss, could involve complete 
removal of the dysfunctional tissue and replacement with a new structure. Tissue engineering, or creation 
of new tissue from cells in vitro, may offer a means to reproduce the otherwise unmatched vibratory VF. 
Success would require that the tissue replacement incorporate well in the larynx, restore vibratory 
function, and not suffer from scar formation during wound healing.   Prior work developed an adipose-
derived multipotent stem cell-based structure that resembled VF epithelium and lamina propria in cell 
phenotype, cell density, ECM fiber density, and mechanical stiffness12-13. This structure is termed the 
Cell-based Outer Vocal fold Replacement (COVR), in distinction from a complete VF replacement which 
would include thyroarytenoid muscle. The purpose of this study was to implant the COVR in a rabbit VF 
resection model, assessing its function relative to injured controls and to autologous VF mucosa 
replantation. The hypothesis was that the cell-based implant would temper the initial wound healing 
response, ultimately leading to reduced fibrosis.  
 
METHODS 
COVR development in vitro 
Inguinal fat from male rabbits was digested in 0.1% type I collagenase, as previously described14, 
15
. After centrifugation, infranatant was washed free of lipid and red blood cells. The resulting 
stromovascular fraction was plated in culture. Adherent adipose-derived stem cells (ASC) were harvested 
at third passage. Cell multipotency was confirmed by differentiation to osteogenic and adipogenic 
phenotypes14,15. 
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Cell-based constructs were formed within 12 mm Corning Transwell culture inserts12. Rabbit 
fibrinogen at 5 mg/ml was mixed in a 4:1:1 ratio with bovine thrombin (2 units/mL in HBS with CaCl2) 
and cell suspension (6x106 cells/ml) to form fibrin gels with embedded ASC. After gelation, additional 
ASC were pipetted onto the surface to replicate an epithelial layer. Culture medium within the annulus 
supplied the tissue constructs only through the insert base. Medium contained 10% fetal bovine serum 
and 10ng/ml epidermal growth factor, and was changed every 2-3 days for 2 weeks. 
 
Rabbit laryngeal surgeries 
 Sixteen New Zealand white rabbits, weighing 2.8-3.5 kg, underwent survival surgeries as 
summarized in Table I and as detailed previously16,17. After laryngofissure, the membranous cover layer 
was resected from the left true vocal fold (known in rabbits as the inferior division of the thyroarytenoid 
fold) by sharp dissection. Cordectomy extended from the anterior commissure to the vocal process of the 
arytenoid cartilage, at the interface between lamina propria and thyroarytenoid muscle, equivalent to 
European Laryngological Society (ELS) type 2 cordectomy.  All right vocal folds remained as uninjured 
controls. Immediately following resection, one of three reconstructions was performed. Six rabbits had 
immediate replacement of the resected cover16. Four sutures of 6-0 plain gut at the corners of the 
replanted tissue secured it in position, and fibrin glue prepared from rabbit fibrinogen was applied at the 
interface to ensure adhesion. Eight rabbits had COVR implants with male ASC, similarly secured. Two 
rabbits served as injured controls and were treated only with fibrin glue over the defect. Five rabbits (one 
autologous replant, two COVRs, and two controls) underwent endoscopy at two weeks post-op.  All were 
euthanized after four weeks and larynges harvested. 
 
Phonation 
Larynges were phonated at 4 weeks post-surgery, either in vivo or after euthanasia and larynx 
harvest, as indicated in Table I 16,17.  Two animals (#7 and 8) had both methods for direct comparison. In 
vivo phonation was performed under anesthesia with VF exposed via thyrohyoid pharyngotomy. An 
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endotracheal tube supplied airflow through the glottis, and manual thyroid cartilage pressure adducted the 
vocal folds. Later implants underwent fresh excised larynx phonation immediately after harvest for 
experimental simplicity. An adduction suture was placed through both vocal processes, and larynges were 
mounted on a PVC pipe with regulated and humidified airflow. In both settings, a high-speed digital 
videocamera recorded vibration at 8,000 frames per second, and acoustic output was recorded. A Matlab 
algorithm converted two-second vibration segments to a kymogram, performed at the midpoint of the 
membranous vocal folds. Qualitative assessment was made of vocal fold appearance, glottic closure, and 
mucosal wave symmetry.  
  
Microscopy 
Larynges were harvested maintaining their orientation, formalin-fixed, paraffin-embedded, and  
sectioned. Histologic stains included H&E, Masson’s trichrome, elastin von Gieson, Alcian blue for 
mucopolysaccharides, Von Kossa for mineralization, oil red O for lipids, and PTAH for fibrin. 
Immunohistochemistry assessed vimentin (AMF17B, DSHB, University of Iowa) and cytokeratin 
(Abcam ab961) expression, using normal rabbit larynx for comparison. 
 
RESULTS 
In vitro phenotypes  
 Rabbit ASC deposited lipid and mineral under adipogenic and osteogenic culture conditions, 
confirming their multi-potency15. No deposits were detected in three-dimensional COVR culture, 
confirming that unwanted spontaneous differentiation did not occur.  All rabbit ASC throughout the 
COVR maintained vimentin expression without significant cytokeratin expression, indicating 
mesenchymal phenotype. 
 
Rabbit survival surgeries  
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Treatments and assessments of 16 rabbits are summarized in chronological order in Table 1. 
Operations performed were autologous mucosa replantation (n=6), COVR implant (n=8), and unilateral 
cordectomy only (n=2). One animal died from inadequate hemostasis causing a tracheal hematoma. 
Remaining animals survived without complication, maintained oral intake, and gained weight.  Five had 
endoscopy after two weeks (Figure 1). 
 
 
Phonatory vibration 
One month after surgery, phonatory vibration was recorded with high-speed video either in vivo 
or after larynx excision. Two pilot animals undergoing both methods confirmed that results were similar. 
All larynges produced sound in response to transglottic airflow. Autologous replant and COVR animals 
consistently achieved closure of the membranous glottis, whereas injured controls only closed the 
superior vocal folds (Figure 2). Injured controls demonstrated significant phase asymmetry. Contralateral 
vocal fold vibration was also severely disrupted. This is attributed to poor entrainment of the normal 
vocal fold with the injured side, and has also been observed in an excised larynx injury model18. In 
contrast, both vocal folds participated in phonation after autologous replants or COVR implants; COVR 
symmetry appeared improved.  
 
Histology 
By 4 weeks, all vocal folds had re-epithelialized, and cells populated the entire tissue (Figure 3). 
Unreconstructed cordectomy showed superficial edema overlying dense collagenous fibrosis, seen as blue 
fibers on Masson's trichrome staining. Thickened elastic fibers remained at the base of the resection near 
the thyroarytenoid muscle.  
After autologous mucosa replant, two of the five animals had increased collagen throughout the 
lamina propria relative to contralateral uninjured controls. Elastic fibers were present in all replanted 
Page 8 of 24
John Wiley & Sons
The Laryngoscope
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  9 
mucosae, although some had a disorganized appearance with disruption of the normal fine transverse 
elastic fibers. Mucopolysaccharides were preserved.  
Four weeks after COVR, the implant was difficult to distinguish from surrounding vocal fold 
tissue.  Residual suture securing the implant corners positively identified the implant site in some 
sections. In all sex-matched animals (male ASC implanted into male rabbits), collagen content appeared 
equivalent to contralateral controls and inflammatory cells were not appreciated. All sex-mismatched 
implants (male ASC in female rabbits) demonstrated increased collagen and notable inflammatory 
infiltrate in both the operated and control sides. In both genders, elastic fibers within adjacent native vocal 
fold were discontinued at the injury edge. Mature elastic fibers were not identified with elastin von 
Gieson staining within the definitive implant sites. Elastic fibers occasionally detected in deep tissue near 
the thyroarytenoid muscle may have been spared from resection. Those fibers appeared similar to 
unoperated vocal folds and were not thickened. Mucopolysaccharide staining was present within COVR 
implants to a lesser degree than in autologous mucosa replants (Figure 4). 
The fibrin-ASC COVR prior to implant showed a bland, uniform structure without detectable 
collagen or elastic fibers.  That provisional fibrin matrix was partially detected four weeks after implant in 
two of eight animals. PTAH staining shows fibrin as fine bluish fibers within the granulation tissue of the 
implant site (Figure 5).   
 
 
DISCUSSION  
Study summary 
This work furthers the development of a cell-based replacement for the vocal fold mucosa. A 
tissue-engineered structure containing adipose-derived mesenchymal stem cells was successfully 
engrafted onto rabbit vocal folds wounded by complete epithelium and lamina propria resection.  The 
COVR implant (Cell-based Outer Vocal fold Replacement) produced excellent short-term function after 
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four weeks of integration. Results were superior to autologous replantation of structurally intact vocal 
fold mucosa, and greatly improved over healing by secondary intention. 
This work hypothesized that implanted cells and scaffold would influence host wound healing, 
manipulating the cellular response and ECM remodeling to result in a functional vibratory mucosa 
without fibrosis. Although the four-week timepoint studied here only represents acute results, it is 
apparent that the early wound healing process is tempered.  Cordectomy injury produced edema, collagen 
deposition, and distortion of residual deep lamina propria ECM. Those processes did not occur in gender-
matched COVR implants. Reconstructing with autologous mucosa replants did abrogate scar formation, 
but to a lesser degree than with the tissue-engineered COVR. Comparing the COVR with complete 
mucosal replant suggests that undifferentiated ASC in fibrin may guide wound healing with less fibrosis 
than the differentiated vocal fold cells can. Also, the freshly resected mucosal transplant contained a 
mature and ideal ECM structure. That ECM was disrupted during the first month after surgery, and its 
vibration impaired relative to normal. Thus, implanting a complete ECM is only beneficial if wound 
healing can be tailored to prevent damage.  
An unanticipated sex difference was identified in the COVR implant animals. Female rabbits 
receiving male cells showed clearly more inflammation and fibrosis then male rabbits receiving 
allogeneic male cells.  It is unclear from this early finding whether the greater inflammatory activity in 
females was due to the antigenicity of male cells, or to an inherently more inflammatory phenotype in the 
female rabbits.  
 
Tissue-engineering the vocal folds 
The concept of a cell-populated, three-dimensional, tissue-engineered structure for vocal fold 
reconstruction was first described in 200912. It was proposed as an alternative to injectable therapies of 
biomaterials and/or cells for lamina propria regeneration. Motivation for this more radical approach came 
from the observation that remodeling existing scar was likely to fail in a subset of severely affected 
patients19. Also, injectables alone are not feasible for acute reconstruction after vocal fold cordectomy. 
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Other variations of three-dimensional tissue-engineered vocal fold replacement have since been proposed, 
using alternate cell sources and materials20-22. The encouraging findings from multiple investigators 
support the feasibility of this general approach.  The optimal composition can now be fine-tuned, and may 
depend on clinical practicality as much as results from animal models. For example, cell availability, 
simple processing, and minimal risk of serious adverse events are all practical requirements for this 
elective therapy.  
The COVR proposed in this work aims to regenerate vibratory vocal fold mucosa with an 
autologous-derived implant. It would be applied after complete scar resection, with repair controlled by 
both the fibrin scaffold and the embedded cells. Fibrin, the acellular component of blood clots, is a 
bioactive protein supporting numerous actions including angiogenesis, elastogenesis, and cell migration23-
25
. The provisional fibrous structure guides deposition of new matrix in an orderly manner26. As it 
degrades by enzymatic fibrinolysis, the released peptide fragments act upon surrounding cells in a 
feedback loop to control the remodeling rate27. The adipose-derived stem cells are essential regulators of 
matrix remodeling in this system. ASC downregulate mRNA for collagens I and III and α-smooth muscle 
actin in vocal fold fibroblasts28. The native fibroblasts therefore becomes less fibrotic and less contractile, 
both protecting the airy lamina propria matrix. These ASC effects translated to reduced collagen 
deposition when implanted within canine lamina propria29. 
ASC also have broad and strong immunosuppressive actions that influence, but do not eliminate, 
the local host response.  Through a number of cytokine effects and direct cell-cell contact, they reduce 
cytotoxic T-cell proliferation, prevent dendritic cell differentiation, inhibit natural killer cell function, and 
induce regulatory T cell and B cell pathways which in turn promote immune tolerance30-32.  In this study, 
male ASC implants in male rabbits had very little inflammatory infiltrate at 4 weeks. In contrast, male 
ASC implants in female rabbits had significant inflammatory cells and greater collagen deposition, 
consistent with the widespread association between inflammation and fibrosis33. The findings do confirm 
that cell- or antibody-mediated immune reactivity can target ASC in the vocal fold implants (as elsewhere 
in the body), and adversely effects graft outcomes. All study animals received allogeneic transplants (cells 
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from non-host animals), but perhaps the narrow genetic profile of New Zealand white rabbits shielded the 
same-sex implants from immune recognition. Alternatively, female rabbits could be predisposed to 
greater immune reactivity and fibrosis. The difference is relevant to the therapeutic success in females, 
and warrants further study. Sex is only beginning to be appreciated as a biological variable, and the 
literature at this point is too sparse to extrapolate to the VF.   
 
Future directions 
These studies demonstrate promising wound healing with a tissue-engineered vocal fold mucosa 
implanted in rabbits at the time of acute injury.  This scenario most resembles a cordectomy resection of 
extensive scar or of epithelial carcinoma.  Further investigation is required to better model both of those 
human conditions. First, this study is not immediately generalizable to the clinical condition of severe 
established vocal fold scar. Altered phenotype of scar fibroblasts, or vascular insufficiency in the wound 
bed, may induce re-fibrosis or impede graft integration. An animal model with injury, scar maturation, 
then delayed COVR implantation would be relevant. Also, longer monitoring is required to assess the 
ultimate ECM structure, which is still evolving at four weeks post-implant.  
Additional concerns face this approach for vocal fold reconstruction in the wake of cancer 
resection. Stem cell reconstruction has been most extensively studied in breast cancer, and remains 
intensely controversial34. An influential mouse study with ductal breast carcinoma cells found increased 
metastases when MSC were administered35; similar results occurred with head and neck cancer cell 
lines36. Nonetheless numerous conflicting animal and human studies have led to uncertainty about long-
term outcomes37. The first likely cancer patients will be those seeking delayed scar treatment years after 
therapy. Additional careful animal research is required before considering stem cell therapy for immediate 
laryngeal cancer reconstruction.  
 
CONCLUSIONS 
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Regenerative medicine for the vocal fold is progressing. This work describes a cell-based outer 
vocal fold replacement (COVR) produced from adipose-derived multi-potent stromal cells and fibrin.  Its 
implantation after type 2 cordectomy in rabbits reduced scarring and enabled symmetric mucosal waves 
during short-term phonation.  Function was better than replanted autologous vocal fold mucosa after one 
month. Long-term evaluation is needed to fully assess functional outcomes.   
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FIGURE LEGENDS 
Figure 1. Endoscopy two weeks after vocal fold cordectomy surgery in rabbits. All images obtained from 
a 0-degree rigid endoscope with CCD camera. A) Normal unoperated cadaveric rabbit; black arrows 
indicate the ventricle dividing the inferior and superior divisions of the thyroarytenoid folds. B) Left-
sided type 2 cordectomy control; early formation of an anterior glottic web demonstrated. C) Autologous 
mucosa replant; white asterisk indicates the surgical site. D) COVR implant; white arrow marks the 
superior edge of the implant site. 
 
Figure 2. Kymograms extracted from high-speed videolaryngoscopy segments. Kymograms were 
performed at the mid-portion of the membranous vocal fold, within the injury region. Operated left vocal 
fold appears as the bottom tracing in each segment. A) Cordectomy control showing markedly irregular 
vibration. B) Autologous mucosa replantation showing regular but asymmetric vibration. C) COVR 
implant with regular and symmetric vibration.  
 
Figure 3. Rabbit vocal fold histology, all at 20X.  Scale bars are 200 microns. Left column is standard 
H&E stain, middle column is Masson's trichrome showing collagen in blue, and right column is elastin 
von Gieson stain with elastic fibers appearing black. Row A, normal unoperated rabbit vocal fold with 
epithelium in the left of each panel and thyroarytenoid muscle in the top right corner. The lamina propria 
network of fine collagen and elastin fibers is demonstrated. Row B, four weeks after ELS type 2 
cordectomy, showing superficial edema and deep fibrosis. Row C, four weeks after cordectomy with 
autologous mucosa replant. Elastic fibers appear thickened relative to unoperated control side, and lamina 
propria is compressed. Row D, four weeks after cordectomy with COVR implantation.  Collagen appears 
similar to unoperated control side; mature elastic fibers are not detected. 
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Figure 4. Alcian blue stain for mucopolysaccharides in rabbit vocal folds, four weeks after surgery. A) 
COVR implant with sparse staining, most prevalent in the superficial region. B) Autologous mucosa 
replant, with preserved staining throughout the tissue. 
 
Figure 5. Fibrin gel histology. A) H&E stain of COVR in vitro at time of implant, 20X. B) PTAH stain 
showing fine bluish fibers suggestive of fibrin, within the COVR implant site after four weeks. Cell 
nuclei also appear blue. 40x. C) Corresponding H&E stain of rabbit COVR implant shown in B, 40X. 
Fibrin is indistinguishable from other matrix on standard stain. 
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Table 1. Operative treatments of 16 rabbits.
Animal Sex Reconstruction Phonation
1 M transplant in vivo
2 M transplant died
3 M transplant in vivo
4 M transplant in vivo
5 M transplant in vivo
6 M transplant in vivo
7 M COVR in vivo, excised
8 M COVR in vivo, excised
9 M COVR excised
10 M COVR excised
11 F COVR excised
12 F COVR excised
13 F COVR excised
14 F COVR excised
15 M fibrin glue excised
16 M fibrin glue excised
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Figure 1. Endoscopy two weeks after vocal fold cordectomy surgery in rabbits. All images obtained from a 0-
degree rigid endoscope with CCD camera. A) Normal unoperated cadaveric rabbit; black arrows indicate the 
ventricle dividing the inferior and superior divisions of the thyroarytenoid folds. B) Left-sided type 2 
cordectomy control; early formation of an anterior glottic web demonstrated. C) Autologous mucosa replant; 
white asterisk indicates the surgical site. D) COVR implant; white arrow marks the superior edge of the 
implant site.  
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Figure 2. Kymograms extracted from high-speed videolaryngoscopy segments. Kymograms were performed 
at the mid-portion of the membranous vocal fold, within the injury region. Operated left vocal fold appears 
as the bottom tracing in each segment. A) Cordectomy control showing markedly irregular vibration. B) 
Autologous mucosa replantation showing regular but asymmetric vibration. C) COVR implant with regular 
and symmetric vibration.  
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Figure 3. Rabbit vocal fold histology, all at 20X.  Scale bars are 200 microns. Left column is standard H&E 
stain, middle column is Masson's trichrome showing collagen in blue, and right column is elastin von Gieson 
stain with elastic fibers appearing black. Row A, normal unoperated rabbit vocal fold with epithelium in the 
left of each panel and thyroarytenoid muscle in the top right corner. The lamina propria network of fine 
collagen and elastin fibers is demonstrated. Row B, four weeks after ELS type 2 cordectomy, showing 
superficial edema and deep fibrosis. Row C, four weeks after cordectomy with autologous mucosa replant. 
Elastic fibers appear thickened relative to unoperated control side, and lamina propria is compressed. Row 
D, four weeks after cordectomy with COVR implantation.  Collagen appears similar to unoperated control 
side; mature elastic fibers are not detected.  
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Figure 4. Alcian blue stain for mucopolysaccharides in rabbit vocal folds, four weeks after surgery. A) COVR 
implant with sparse staining, most prevalent in the superficial region. B) Autologous mucosa replant, with 
preserved staining throughout the tissue.  
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Figure 5. Fibrin gel histology. A) H&E stain of COVR in vitro at time of implant, 20X. B) PTAH stain showing 
fine bluish fibers suggestive of fibrin, within the COVR implant site after four weeks. Cell nuclei also appear 
blue. 40x. C) Corresponding H&E stain of rabbit COVR implant shown in B, 40X. Fibrin is indistinguishable 
from other matrix on standard stain.  
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